Eukaryotic translation initiation factor 4E (eIF4E) is overexpressed early in breast cancers in association with disease progression and reduced survival. Much remains to be understood regarding the role of eIF4E in human cancer. We determined, using immortalized human breast epithelial cells, that elevated expression of eIF4E translationally activates the transforming growth factor  (TGF-) pathway, promoting cell invasion, a loss of cell polarity, increased cell survival, and other hallmarks of early neoplasia. Overexpression of eIF4E is shown to facilitate the selective translation of integrin 1 mRNA, which drives the translationally controlled assembly of a TGF- receptor signaling complex containing ␣31 integrins, -catenin, TGF- receptor I, E-cadherin, and phosphorylated Smad2/3. This receptor complex acutely sensitizes nonmalignant breast epithelial cells to activation by typically substimulatory levels of activated TGF-. TGF- can promote cellular differentiation or invasion and transformation. As a translational coactivator of TGF-, eIF4E confers selective mRNA translation, reprogramming nonmalignant cells to an invasive phenotype by reducing the set point for stimulation by activated TGF-. Overexpression of eIF4E may be a proinvasive facilitator of TGF- activity.T ranslation of mRNA involves the recruitment of ribosomes to the capped end of mRNAs by eukaryotic translation initiation factor 4E (eIF4E), RNA helicase eIF4A, and scaffolding protein eIF4G, which comprise the complex known as eIF4F (1). Increased levels of eIF4E have been shown to selectively stimulate the translation of a subset of mRNAs referred to as being more eIF4E sensitive (2), which includes cyclin D1 (proliferation), cMyc (transformation), and Bcl-x L and survivin (survival), among others (3, 4). The nature of the increased requirement for eIF4E in mRNA translation is complex. While certain mRNAs with long or structured 5= untranslated regions (UTRs) possess a greater requirement for eIF4E (5-7), others do not, implicating a combination of 5= UTR structural and sequence motifs in determining the extent to which eIF4E levels control the translation of certain mRNAs (5, 7-10). In part, the increased requirement for eIF4E of more structured 5= UTR mRNAs can be attributed to the need to recruit greater eIF4A RNA helicase activity, which is controlled by eIF4E (11). The availability of translationally active eIF4E is opposed by the eIF4E binding proteins (4E-BPs), which block the eIF4E interaction with eIF4G (1, 12, 13). The 4E-BPs are activated by the loss of kinase mTORC1 phosphorylation during cell stress, such as hypoxia or nutrient deprivation (1).Considerable research from tissue culture (14), animal tumor models (15-17), and a variety of human cancers (18-23) supports the suggestion that overexpression of eIF4E results in prooncogenic activity. eIF4E overexpression and decreased 4E-BP levels or activity are strongly associated with worse clinical outcomes and decreased survival in many human cancers (2,24,25). In breast an...